<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">34750982</PMID><DateCompleted><Year>2022</Year><Month>03</Month><Day>24</Day></DateCompleted><DateRevised><Year>2022</Year><Month>03</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1755-5949</ISSN><JournalIssue CitedMedium="Internet"><Volume>28</Volume><Issue>1</Issue><PubDate><Year>2022</Year><Month>Jan</Month></PubDate></JournalIssue><Title>CNS neuroscience &amp; therapeutics</Title><ISOAbbreviation>CNS Neurosci Ther</ISOAbbreviation></Journal><ArticleTitle>Amyotrophic lateral sclerosis (ALS) linked mutation in Ubiquilin 2 affects stress granule assembly via TIA-1.</ArticleTitle><Pagination><StartPage>105</StartPage><EndPage>115</EndPage><MedlinePgn>105-115</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1111/cns.13757</ELocationID><Abstract><AbstractText Label="AIMS">The ubiquilin-like protein ubiquilin 2 (UBQLN2) is associated with amyotrophic lateral sclerosis and frontotemporal degeneration (ALS/FTD). The biological function of UBQLN2&#xa0;has previously been shown to be related to stress granules (SGs). In this study, we aimed to clarify the regulatory relationship between UBQLN2 and SGs.</AbstractText><AbstractText Label="METHODS">In this study, we transfected UBQLN2-WT or UBQLN2-P497H plasmids into cell lines (HEK293T, HeLa), and observed the process of SG dynamics by immunofluorescence. Meanwhile, immunoblot analyses the protein changes of stress granules related components.</AbstractText><AbstractText Label="RESULTS">We observed that ubiquilin 2 colocalizes with the SG component proteins G3BP1, TIA-1, ATXN2, and PABPC1. In cells expressing WT UBQLN2 or P497H mutants, in the early stages of SG formation under oxidative stress, the percentage of cells with SGs and the number of SGs per cell decreased to varying degrees. Between WT and mutant, there was no significant difference in eIF2&#x3b1; activity after stress treatment. Interestingly, the UBQLN2 P497H mutant downregulates the level of TIA-1. In addition, the overexpression of the UBQLN2 P497H mutant inhibited the phosphorylation of 4E-BP1 and affected the nucleoplasmic distribution of TDP-43.</AbstractText><AbstractText Label="CONCLUSIONS">Ubiquilin 2 colocalizes with the SG component proteins G3BP1, TIA-1, ATXN2, and PABPC1. It participates in regulating SG dynamics. And UBQLN2&#xa0;mutation affects the assembly of stress granules by regulating TIA-1. In addition, the overexpression of the UBQLN2 P497H mutant inhibited the phosphorylation of 4E-BP1 and affected the nuclear and cytoplasmic distribution of TDP-43. These provide new insights into the role of UBQLN2 in oxidative stress and the pathogenesis of ALS.</AbstractText><CopyrightInformation>&#xa9; 2021 The Authors. CNS Neuroscience &amp; Therapeutics published by John Wiley &amp; Sons Ltd.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Peng</LastName><ForeName>Guangnan</ForeName><Initials>G</Initials><Identifier Source="ORCID">0000-0002-5586-0759</Identifier><AffiliationInfo><Affiliation>Center for Medical Genetics &amp; Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gu</LastName><ForeName>Ao</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center for Medical Genetics &amp; Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niu</LastName><ForeName>Hongyan</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Center for Medical Genetics &amp; Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Linlin</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Center for Medical Genetics &amp; Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center for Medical Genetics &amp; Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhou</LastName><ForeName>Miaojin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Center for Medical Genetics &amp; Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yiti</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Center for Medical Genetics &amp; Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Jie</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center for Regenerative Medicine, The First People's Hospital of Yunnan Province, Kunming, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Licong</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>School of Life Sciences, Central South University, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Desheng</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Center for Medical Genetics &amp; Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Key Laboratory of Basic and Applied Hematology, Central South University, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Xionghao</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Center for Medical Genetics &amp; Hunan Key Laboratory of Medical Genetics, School of Life Sciences, Central South University, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Key Laboratory of Basic and Applied Hematology, Central South University, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Key Laboratory of Animal Models for Human Diseases, Central South University, Hunan, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Mujun</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Hunan Key Laboratory of Basic and Applied Hematology, Central South University, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Hunan Key Laboratory of Animal Models for Human Diseases, Central South University, Hunan, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Cell Biology, School of Life Sciences, Central South University, Hunan, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2021</Year><Month>11</Month><Day>08</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>CNS Neurosci Ther</MedlineTA><NlmUniqueID>101473265</NlmUniqueID><ISSNLinking>1755-5930</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D048868">Adaptor Proteins, Signal Transducing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000071183">Autophagy-Related Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000075223">Poly-ADP-Ribose Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000067776">RNA Recognition Motif Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000074019">T-Cell Intracellular Antigen-1</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C071558">TIA1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C405662">UBQLN2 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.-</RegistryNumber><NameOfSubstance UI="D004265">DNA Helicases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.12</RegistryNumber><NameOfSubstance UI="C116070">G3BP1 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D020365">RNA Helicases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D048868" MajorTopicYN="N">Adaptor Proteins, Signal Transducing</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000071183" MajorTopicYN="N">Autophagy-Related Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004265" MajorTopicYN="N">DNA Helicases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D057180" MajorTopicYN="N">Frontotemporal Dementia</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057809" MajorTopicYN="N">HEK293 Cells</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000075223" MajorTopicYN="N">Poly-ADP-Ribose Binding Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020365" MajorTopicYN="N">RNA Helicases</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000067776" MajorTopicYN="N">RNA Recognition Motif Proteins</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000088162" MajorTopicYN="Y">Stress Granules</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000074019" MajorTopicYN="N">T-Cell Intracellular Antigen-1</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">TIA-1</Keyword><Keyword MajorTopicYN="N">UBQLN2</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">protein aggregation</Keyword><Keyword MajorTopicYN="N">stress granules</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>9</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>7</Month><Day>7</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>10</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2021</Year><Month>11</Month><Day>10</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>3</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2021</Year><Month>11</Month><Day>9</Day><Hour>7</Hour><Minute>20</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">34750982</ArticleId><ArticleId IdType="pmc">PMC8673703</ArticleId><ArticleId IdType="doi">10.1111/cns.13757</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Vasconcelos K, Oliveira ASB, Fuchs LFP, et al. Action of hormonal therapy in amyotrophic lateral sclerosis: a systematic review. Rev Assoc Med Bras (1992). 2020;66(11):1589&#x2010;1594.</Citation><ArticleIdList><ArticleId IdType="pubmed">33295415</ArticleId></ArticleIdList></Reference><Reference><Citation>Amin A, Perera ND, Beart PM, Turner BJ, Shabanpoor F. Amyotrophic lateral sclerosis and autophagy: dysfunction and therapeutic targeting. Cells. 2020;9(11):2413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7694295</ArticleId><ArticleId IdType="pubmed">33158177</ArticleId></ArticleIdList></Reference><Reference><Citation>Grossman M. Amyotrophic lateral sclerosis &#x2010; a multisystem neurodegenerative disorder. Nat Rev Neurol. 2019;15(1):5&#x2010;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">30446736</ArticleId></ArticleIdList></Reference><Reference><Citation>Talbott EO, Malek AM, Lacomis D. The epidemiology of amyotrophic lateral sclerosis. Handb Clin Neurol. 2016;138:225&#x2010;238.</Citation><ArticleIdList><ArticleId IdType="pubmed">27637961</ArticleId></ArticleIdList></Reference><Reference><Citation>Watanabe Y. Amyotrophic lateral sclerosis and frontotemporal dementia. Brain Nerve. 2019;71(11):1227&#x2010;1235.</Citation><ArticleIdList><ArticleId IdType="pubmed">31722308</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinn C, Elman L. Amyotrophic lateral sclerosis and other motor neuron diseases. Continuum (Minneap Minn). 2020;26(5):1323&#x2010;1347.</Citation><ArticleIdList><ArticleId IdType="pubmed">33003004</ArticleId></ArticleIdList></Reference><Reference><Citation>Deng HX, Chen W, Hong ST, et al. Mutations in UBQLN2 cause dominant X&#x2010;linked juvenile and adult&#x2010;onset ALS and ALS/dementia. Nature. 2011;477(7363):211&#x2010;215.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3169705</ArticleId><ArticleId IdType="pubmed">21857683</ArticleId></ArticleIdList></Reference><Reference><Citation>Farrawell NE, McAlary L, Lum JS, et al. Ubiquitin homeostasis is disrupted in TDP&#x2010;43 and FUS cell models of ALS. iScience. 2020;23(11):101700.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7644588</ArticleId><ArticleId IdType="pubmed">33196025</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu Q, Liu M, Huang C, et al. Pathogenic Ubqln2 gains toxic properties to induce neuron death. Acta Neuropathol. 2015;129(3):417&#x2010;428.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4777328</ArticleId><ArticleId IdType="pubmed">25388785</ArticleId></ArticleIdList></Reference><Reference><Citation>Renaud L, Picher&#x2010;Martel V, Codron P, Julien JP. Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia. Acta Neuropathol Commun. 2019;7(1):103.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6889556</ArticleId><ArticleId IdType="pubmed">31319884</ArticleId></ArticleIdList></Reference><Reference><Citation>Osaka M, Ito D, Suzuki N. Disturbance of proteasomal and autophagic protein degradation pathways by amyotrophic lateral sclerosis&#x2010;linked mutations in ubiquilin 2. Biochem Biophys Res Commun. 2016;472(2):324&#x2010;331.</Citation><ArticleIdList><ArticleId IdType="pubmed">26944018</ArticleId></ArticleIdList></Reference><Reference><Citation>Senturk M, Lin G, Zuo Z, et al. Ubiquilins regulate autophagic flux through mTOR signalling and lysosomal acidification. Nat Cell Biol. 2019;21(3):384&#x2010;396.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6534127</ArticleId><ArticleId IdType="pubmed">30804504</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Klionsky DJ. A novel role of UBQLNs (ubiquilins) in regulating autophagy, MTOR signaling and v&#x2010;ATPase function. Autophagy. 2020;16(1):1&#x2010;2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6984483</ArticleId><ArticleId IdType="pubmed">31516068</ArticleId></ArticleIdList></Reference><Reference><Citation>Aulas A, Vande VC. Alterations in stress granule dynamics driven by TDP&#x2010;43 and FUS: a link to pathological inclusions in ALS? Front Cell Neurosci. 2015;9:423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4615823</ArticleId><ArticleId IdType="pubmed">26557057</ArticleId></ArticleIdList></Reference><Reference><Citation>Guil S, Long JC, C&#xe1;ceres JF. hnRNP A1 relocalization to the stress granules reflects a role in the stress response. Mol Cell Biol. 2006;26(15):5744&#x2010;5758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1592774</ArticleId><ArticleId IdType="pubmed">16847328</ArticleId></ArticleIdList></Reference><Reference><Citation>Farace C, Fenu G, Lintas S, et al. Amyotrophic lateral sclerosis and lead: a systematic update. Neurotoxicology. 2020;81:80&#x2010;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">32941938</ArticleId></ArticleIdList></Reference><Reference><Citation>Ratti A, Gumina V, Lenzi P, et al. Chronic stress induces formation of stress granules and pathological TDP&#x2010;43 aggregates in human ALS fibroblasts and iPSC&#x2010;motoneurons. Neurobiol Dis. 2020;145:105051.</Citation><ArticleIdList><ArticleId IdType="pubmed">32827688</ArticleId></ArticleIdList></Reference><Reference><Citation>Jain S, Wheeler JR, Walters RW, Agrawal A, Barsic A, Parker R. ATPase&#x2010;modulated stress granules contain a diverse proteome and substructure. Cell. 2016;164(3):487&#x2010;498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4733397</ArticleId><ArticleId IdType="pubmed">26777405</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexander EJ, Ghanbari Niaki A, Zhang T, et al. Ubiquilin 2 modulates ALS/FTD&#x2010;linked FUS&#x2010;RNA complex dynamics and stress granule formation. Proc Natl Acad Sci USA. 2018;115(49):E11485&#x2010;E11494.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6298105</ArticleId><ArticleId IdType="pubmed">30442662</ArticleId></ArticleIdList></Reference><Reference><Citation>Riggs CL, Kedersha N, Ivanov P, Anderson P. Mammalian stress granules and P bodies at a glance. J Cell Sci. 2020;133(16):jcs242487.</Citation><ArticleIdList><ArticleId IdType="pubmed">32873715</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang P, Mathieu C, Kolaitis RM, et al. G3BP1 is a tunable switch that triggers phase separation to assemble stress granules. Cell. 2020;181(2):325&#x2010;345.e28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7448383</ArticleId><ArticleId IdType="pubmed">32302571</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang I, Hennig J, Jagtap PK, Sonntag M, Valcarcel J, Sattler M. Structure, dynamics and RNA binding of the multi&#x2010;domain splicing factor TIA&#x2010;1. Nucleic Acids Res. 2014;42(9):5949&#x2010;5966.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4027183</ArticleId><ArticleId IdType="pubmed">24682828</ArticleId></ArticleIdList></Reference><Reference><Citation>Gilks N, Kedersha N, Ayodele M, et al. Stress granule assembly is mediated by prion&#x2010;like aggregation of TIA&#x2010;1. Mol Biol Cell. 2004;15(12):5383&#x2010;5398.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC532018</ArticleId><ArticleId IdType="pubmed">15371533</ArticleId></ArticleIdList></Reference><Reference><Citation>Beyer L, Gunther R, Koch JC, et al. TDP&#x2010;43 as structure&#x2010;based biomarker in amyotrophic lateral sclerosis. Ann Clin Transl Neurol. 2021;8(1):271&#x2010;277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7818221</ArticleId><ArticleId IdType="pubmed">33263951</ArticleId></ArticleIdList></Reference><Reference><Citation>Fournier MJ, Coudert L, Mellaoui S, et al. Inactivation of the mTORC1&#x2010;eukaryotic translation initiation factor 4E pathway alters stress granule formation. Mol Cell Biol. 2013;33(11):2285&#x2010;2301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3648080</ArticleId><ArticleId IdType="pubmed">23547259</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim SH, Stiles SG, Feichtmeier JM, et al. Mutation&#x2010;dependent aggregation and toxicity in a drosophila model for UBQLN2&#x2010;associated ALS. Hum Mol Genet. 2018;27(2):322&#x2010;337.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5886165</ArticleId><ArticleId IdType="pubmed">29161404</ArticleId></ArticleIdList></Reference><Reference><Citation>Laura D, Anna P, Nicola F, Loriano B, Rigers B, Gianfranco S. Stress granules in Ciona robusta: first evidences of TIA&#x2010;1&#x2010;related nucleolysin and tristetraprolin gene expression under metal exposure. Comp Biochem Physiol C Toxicol Pharmacol. 2021;243:108977.</Citation><ArticleIdList><ArticleId IdType="pubmed">33465518</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuan Z, Jiao B, Hou L, et al. Mutation analysis of the TIA1 gene in Chinese patients with amyotrophic lateral sclerosis and frontotemporal dementia. Neurobiol Aging. 2018;64(160):160.e9&#x2010;160.e12.</Citation><ArticleIdList><ArticleId IdType="pubmed">29370934</ArticleId></ArticleIdList></Reference><Reference><Citation>Mackenzie IR, Nicholson AM, Sarkar M, et al. TIA1 mutations in amyotrophic lateral sclerosis and frontotemporal dementia promote phase separation and alter stress granule dynamics. Neuron. 2017;95(4):808&#x2010;816.e9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5576574</ArticleId><ArticleId IdType="pubmed">28817800</ArticleId></ArticleIdList></Reference><Reference><Citation>Weskamp K, Barmada SJ. TDP43 and RNA instability in amyotrophic lateral sclerosis. Brain Res. 2018;1693(Pt A):67&#x2010;74.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5997512</ArticleId><ArticleId IdType="pubmed">29395044</ArticleId></ArticleIdList></Reference><Reference><Citation>Archbold HC, Jackson KL, Arora A, et al. TDP43 nuclear export and neurodegeneration in models of amyotrophic lateral sclerosis and frontotemporal dementia. Sci Rep. 2018;8(1):4606.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5854632</ArticleId><ArticleId IdType="pubmed">29545601</ArticleId></ArticleIdList></Reference><Reference><Citation>Barmada SJ, Serio A, Arjun A, et al. Autophagy induction enhances TDP43 turnover and survival in neuronal ALS models. Nat Chem Biol. 2014;10(8):677&#x2010;685.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4106236</ArticleId><ArticleId IdType="pubmed">24974230</ArticleId></ArticleIdList></Reference><Reference><Citation>Mertens J, Paquola ACM, Ku M, et al. Directly reprogrammed human neurons retain aging&#x2010;associated transcriptomic signatures and reveal age&#x2010;related nucleocytoplasmic defects. Cell Stem Cell. 2015;17(6):705&#x2010;718.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5929130</ArticleId><ArticleId IdType="pubmed">26456686</ArticleId></ArticleIdList></Reference><Reference><Citation>Malcova I, Senohrabkova L, Novakova L, Hasek J. eIF3a destabilization and TDP&#x2010;43 alter dynamics of heat&#x2010;induced stress granules. Int J Mol Sci. 2021;22(10):5164.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8153170</ArticleId><ArticleId IdType="pubmed">34068231</ArticleId></ArticleIdList></Reference><Reference><Citation>Heberle AM, Razquin Navas P, Langelaar&#x2010;Makkinje M, et al. The PI3K and MAPK/p38 pathways control stress granule assembly in a hierarchical manner. Life Sci Alliance. 2019;2(2):e201800257.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6441495</ArticleId><ArticleId IdType="pubmed">30923191</ArticleId></ArticleIdList></Reference><Reference><Citation>Lutz C. Mouse models of ALS: past, present and future. Brain Res. 2018;1693(Pt A):1&#x2010;10.</Citation><ArticleIdList><ArticleId IdType="pubmed">29577886</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei H, Dirren E, Poitry&#x2010;Yamate C, Schneider BL, Gruetter R, Aebischer P. Evolution of the neurochemical profiles in the G93A&#x2010;SOD1 mouse model of amyotrophic lateral sclerosis. J Cereb Blood Flow Metab. 2019;39(7):1283&#x2010;1298.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6668519</ArticleId><ArticleId IdType="pubmed">29400109</ArticleId></ArticleIdList></Reference><Reference><Citation>Tefera TW, Borges K. Neuronal glucose metabolism is impaired while astrocytic TCA cycling is unaffected at symptomatic stages in the hSOD1(G93A) mouse model of amyotrophic lateral sclerosis. J Cereb Blood Flow Metab. 2019;39(9):1710&#x2010;1724.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6727138</ArticleId><ArticleId IdType="pubmed">29553298</ArticleId></ArticleIdList></Reference><Reference><Citation>de Munter J, Shafarevich I, Liundup A, et al. Neuro&#x2010;Cells therapy improves motor outcomes and suppresses inflammation during experimental syndrome of amyotrophic lateral sclerosis in mice. CNS Neurosci Ther. 2020;26(5):504&#x2010;517.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7163689</ArticleId><ArticleId IdType="pubmed">31867846</ArticleId></ArticleIdList></Reference><Reference><Citation>Shang HY, Zhang JJ, Fu ZF, et al. Therapeutic effects of hirsutella sinensis on the disease onset and progression of amyotrophic lateral sclerosis in SOD1(G93A) transgenic mouse model. CNS Neurosci Ther. 2020;26(1):90&#x2010;100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6930832</ArticleId><ArticleId IdType="pubmed">31318169</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang K, Wang A, Zhong K, et al. UBQLN2&#x2010;HSP70 axis reduces poly&#x2010;Gly&#x2010;Ala aggregates and alleviates behavioral defects in the C9ORF72 animal model. Neuron. 2021;109(12):1949&#x2010;1962.e6.</Citation><ArticleIdList><ArticleId IdType="pubmed">33991504</ArticleId></ArticleIdList></Reference><Reference><Citation>Gorrie GH, Fecto F, Radzicki D, et al. Dendritic spinopathy in transgenic mice expressing ALS/dementia&#x2010;linked mutant UBQLN2. Proc Natl Acad Sci USA. 2014;111(40):14524&#x2010;14529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4209984</ArticleId><ArticleId IdType="pubmed">25246588</ArticleId></ArticleIdList></Reference><Reference><Citation>Ceballos&#x2010;Diaz C, Rosario AM, Park HJ, et al. Viral expression of ALS&#x2010;linked ubiquilin&#x2010;2 mutants causes inclusion pathology and behavioral deficits in mice. Mol Neurodegener. 2015;10:25.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4495639</ArticleId><ArticleId IdType="pubmed">26152284</ArticleId></ArticleIdList></Reference><Reference><Citation>Radzicki D, Liu E, Deng HX, Siddique T, Martina M. Early impairment of synaptic and intrinsic excitability in mice expressing ALS/dementia&#x2010;linked mutant UBQLN2. Front Cell Neurosci. 2016;10:216.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5028382</ArticleId><ArticleId IdType="pubmed">27703430</ArticleId></ArticleIdList></Reference><Reference><Citation>Picher&#x2010;Martel V, Renaud L, Bareil C, Julien JP. Neuronal expression of UBQLN2(P497H) exacerbates TDP&#x2010;43 pathology in TDP&#x2010;43(G348C) mice through interaction with ubiquitin. Mol Neurobiol. 2019;56(7):4680&#x2010;4696.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6647471</ArticleId><ArticleId IdType="pubmed">30377984</ArticleId></ArticleIdList></Reference><Reference><Citation>Hjerpe R, Bett JS, Keuss MJ, et al. UBQLN2 mediates autophagy&#x2010;independent protein aggregate clearance by the proteasome. Cell. 2016;166(4):935&#x2010;949.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5003816</ArticleId><ArticleId IdType="pubmed">27477512</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>